Sutib 50mg Capsule contains Sunitinib Malate, a targeted cancer treatment used for managing advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 28 Capsules in 1 Box |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Glenza 40 mg capsule has enzalutamide in it and is used to treat advanced prostate cancer, particularly in men whose cancer does not respond to hormone therapy, regardless of whether it has spread to other parts of the body.
| Composition | Enzalutamide |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 14 Capsules in a Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Glenvas 10mg Capsule contains Lenvatinib, an oral targeted therapy used to treat certain types of advanced cancers, including thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.
| Composition | Lenvatinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid, Liver & Kidney Cancer |
| Expiry | December 2027 |
Evermil 5mg tablet contains Everolimus, an anti-cancer medicine used to treat certain types of advanced kidney cancer, breast cancer, neuroendocrine tumors, and tuberous sclerosis-related conditions.
| Composition | Everolimus |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Neuroendocrine Tumors, Kidney & Breast Cancer |
| Expiry | December 2027 |
Abirapro 250mg Tablet contains Abiraterone Acetate, a hormone therapy used in the treatment of advanced prostate cancer.
| Composition | Abiraterone Acetate (250mg) |
| Manufacturer | Glenmark Pharmaceuticals |
| Packing | 120 tablets in 1 bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
